Jeffry Weinhuff is the founder and Managing Partner / Chief Investment Officer of Visionary Venture Fund, one of the most active investors in the eye for both pharmaceuticals and medical devices. Visionary’s unique model of partnering with 90 Key Opinion Leader Eye Care Professionals provides unique insights into clinical benefits of emerging companies as well as creates a strong pipeline of new opportunities. Mr. Weinhuff has been an active participant in the Private Equity and Venture Capital area for over 35 years. In addition to his role at Visionary, Mr. Weinhuff is the Executive Chairman of Orasis Pharmaceuticals, Board Chairman of Sydnexis Pharmaceuticals, Board Member of Iantrek and Surface Pharmaceuticals, and previously board member for a number of device and pharmaceutical companies focused on the eye.
Visionary Ventures
Life sciences venture capital fund investing in ophthalmology and medical aesthetics.
